House oversight panel seeks testimony from 'Pharma Bro' Shkreli Staff
Posted: Jan 15, 2016 4:14 PM
WASHINGTON (Reuters) - A U.S. congressional panel is asking pharmaceutical entrepreneur Martin Shkreli to testify at a Jan. 26 hearing about his company's decision to raise the price of a life-saving prescription drug, according to a Republican committee staffer.

Recommended Townhall Video